Biodistribution characteristics of all-trans retinoic acid incorporated in liposomes and polymeric micelles following intravenous administration

被引:39
作者
Kawakami, S
Opanasopit, P
Yokoyama, M
Chansri, N
Yamamoto, T
Okano, T
Yamashita, F
Hashida, M [1 ]
机构
[1] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Sakyo Ku, Kyoto 6068501, Japan
[2] Tokyo Womens Med Univ, Inst Biomed Engn, Shinjyuku Ku, Tokyo 1628666, Japan
[3] Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan
关键词
controlled delivery; controlled release; liposomes; nanoparticles; polymeric drug delivery systems; all-trans retinoic acid; polymeric micelle;
D O I
10.1002/jps.20487
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The aim of this study was to investigate the biodistribution characteristics of all-trans retinoic acid (ATRA) incorporated in liposomes and polymeric micelles following intravenous administration. [H-3] ATRA were incorporated in distearoylphosphatidylcholine (DSPC)/cholesterol (6:4) liposomes. Two types of block copolymers, poly (ethylene glycol)-b-poly-(aspartic acid) derivatives with benzyl (Bz-75) groups, were synthesized to prepare the polymeric micelles for [H-3]ATRA incorporation. ATRA were dissolved in mouse serum to analyze their inherent distribution. After intravenous administration, the blood concentration of [H-3] ATRA in liposomes and polymeric micelles (Bz-75) was higher than that of inherent [H-3]ATRA, suggesting that liposomes and polymeric micelles (Bz-75) control the distribution of ATRA. Pharmacokinetic analysis demonstrated that [H-3]ATRA incorporated in polymeric micelles (Bz-75) exhibit the largest AUC(blood) and lowest hepatic clearance of ATRA, suggesting that polymeric micelles (Bz-75) are an effective ATRA carrier system for acute promyelocytic leukemia (APL) therapy. These results have potential implications for the design of ATRA carriers for APL patients. (c) 2005 Wiley-Liss, Inc. and the American Pharmacists Association.
引用
收藏
页码:2606 / 2615
页数:10
相关论文
共 36 条
[1]  
CASTAIGNE S, 1990, BLOOD, V76, P1704
[2]   Inhibition of tumor growth by biodegradable microspheres containing all-trans-retinoic acid in a human head-and-neck cancer xenograft [J].
Choi, Y ;
Kim, SY ;
Kim, SH ;
Yang, J ;
Park, K ;
Byun, Y .
INTERNATIONAL JOURNAL OF CANCER, 2003, 107 (01) :145-148
[3]   Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid [J].
Douer, D ;
Estey, E ;
Santillana, S ;
Bennett, JM ;
Lopez-Bernstein, G ;
Boehm, K ;
Williams, T .
BLOOD, 2001, 97 (01) :73-80
[4]   Alterations in tretinoin pharmacokinetics following administration of liposomal all-trans retinoic acid [J].
Estey, E ;
Thall, PF ;
Mehta, K ;
Rosenblum, M ;
Brewer, T ;
Simmons, V ;
Cabanillas, F ;
Kurzrock, R ;
LopezBerestein, G .
BLOOD, 1996, 87 (09) :3650-3654
[5]   Molecular remissions induced by liposomal-encapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia [J].
Estey, EH ;
Giles, FJ ;
Kantarjian, H ;
O'Brien, S ;
Cortes, J ;
Freireich, EJ ;
Lopez-Berestein, G ;
Keating, M .
BLOOD, 1999, 94 (07) :2230-2235
[6]   Retinoic acid treatment induces apoptosis or expression of a more differentiated phenotype on different fractions of cultured fetal rat hepatocytes [J].
Falasca, L ;
Favale, A ;
Gualandi, G ;
Maietta, G ;
Devirgiliis, LC .
HEPATOLOGY, 1998, 28 (03) :727-737
[7]   ENHANCED HEPATIC-UPTAKE OF LIPOSOMES THROUGH COMPLEMENT ACTIVATION DEPENDING ON THE SIZE OF LIPOSOMES [J].
HARASHIMA, H ;
SAKATA, K ;
FUNATO, K ;
KIWADA, H .
PHARMACEUTICAL RESEARCH, 1994, 11 (03) :402-406
[8]   Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting [J].
Hattori, Y ;
Kawakami, S ;
Yamashita, F ;
Hashida, M .
JOURNAL OF CONTROLLED RELEASE, 2000, 69 (03) :369-377
[9]   USE OF ALL-TRANS RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA [J].
HUANG, ME ;
YE, YC ;
CHEN, SR ;
CHAI, JR ;
LU, JX ;
ZHOA, L ;
GU, LJ ;
WANG, ZY .
BLOOD, 1988, 72 (02) :567-572
[10]   Phospholipid-based microemulsion formulation of all-trans-retinoic acid for parenteral administration [J].
Hwang, SR ;
Lim, SJ ;
Park, JS ;
Kim, CK .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2004, 276 (1-2) :175-183